1. Home
  2. XGN vs NOTV Comparison

XGN vs NOTV Comparison

Compare XGN & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XGN
  • NOTV
  • Stock Information
  • Founded
  • XGN 2002
  • NOTV 1974
  • Country
  • XGN United States
  • NOTV United States
  • Employees
  • XGN N/A
  • NOTV N/A
  • Industry
  • XGN Medical Specialities
  • NOTV Biotechnology: Pharmaceutical Preparations
  • Sector
  • XGN Health Care
  • NOTV Health Care
  • Exchange
  • XGN Nasdaq
  • NOTV Nasdaq
  • Market Cap
  • XGN 138.3M
  • NOTV 137.5M
  • IPO Year
  • XGN 2019
  • NOTV 1997
  • Fundamental
  • Price
  • XGN $7.23
  • NOTV $2.05
  • Analyst Decision
  • XGN Strong Buy
  • NOTV Strong Buy
  • Analyst Count
  • XGN 2
  • NOTV 1
  • Target Price
  • XGN $7.50
  • NOTV $5.00
  • AVG Volume (30 Days)
  • XGN 236.6K
  • NOTV 888.5K
  • Earning Date
  • XGN 08-04-2025
  • NOTV 08-07-2025
  • Dividend Yield
  • XGN N/A
  • NOTV N/A
  • EPS Growth
  • XGN N/A
  • NOTV N/A
  • EPS
  • XGN N/A
  • NOTV N/A
  • Revenue
  • XGN $56,724,000.00
  • NOTV $480,402,000.00
  • Revenue This Year
  • XGN $19.39
  • NOTV $4.99
  • Revenue Next Year
  • XGN $13.27
  • NOTV $5.39
  • P/E Ratio
  • XGN N/A
  • NOTV N/A
  • Revenue Growth
  • XGN 1.78
  • NOTV N/A
  • 52 Week Low
  • XGN $1.71
  • NOTV $1.15
  • 52 Week High
  • XGN $7.95
  • NOTV $6.48
  • Technical
  • Relative Strength Index (RSI)
  • XGN 56.74
  • NOTV 42.15
  • Support Level
  • XGN $7.10
  • NOTV $2.64
  • Resistance Level
  • XGN $7.95
  • NOTV $3.19
  • Average True Range (ATR)
  • XGN 0.51
  • NOTV 0.33
  • MACD
  • XGN -0.04
  • NOTV -0.09
  • Stochastic Oscillator
  • XGN 46.67
  • NOTV 5.93

About XGN Exagen Inc.

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: